Wednesday, September 9, 2026
spot_img

Total Voting Rights and Transaction in Own Shares

9 September 2026

ICG plc (the “Company”)

Total Voting Rights and Transaction in Own Shares

The Company announces that in the period from 1 September 2026 to 8 September 2026, in accordance with the terms of its share buyback programme announced on 19 February 2026 (the “Share Buyback”), the Company has purchased 706,778 ordinary shares of nominal value of £0.2625 each in the capital of the Company (the “Ordinary Shares“) on the London Stock Exchange through Merrill Lynch International (“BofA Securities”).

The Share Buyback is to enable the Company to issue Ordinary Non-Voting shares to Amundi equal to the number of Ordinary Shares repurchased by the Company in a manner that is non-dilutive to the Company’s existing shareholders in connection with its strategic partnership with Amundi as announced on 18 November 2025 (the “Strategic Partnership Announcement”).

Aggregated Information

Date of Purchase: Aggregate Number of Ordinary Shares Purchased: Lowest Price Paid per Ordinary Share (GBP): Highest Price Paid per Ordinary Share (GBP): Volume-Weighted Average Price Paid per Ordinary Share (GBP):
1 September 2026 119,291 1922.00 pence 1958.00 pence 1942.11 pence
2 September 2026 117,086 1902.00 pence 1936.00 pence 1917.79 pence
3 September 2026 116,793 1902.00 pence 1952.00 pence 1934.09 pence
4 September 2026 118,844 1929.00 pence 1953.00 pence 1940.77 pence
7 September 2026 117,492 1922.00 pence 1940.00 pence 1931.11 pence
8 September 2026 117,272 1920.00 pence 1970.00 pence 1958.29 pence

The Ordinary Shares acquired will be held in Treasury and will, in due course, be cancelled in tranches on at least a bi-annual basis, and will not be used for any other purpose prior to cancellation.

Total Voting Rights

Following the settlement of the Ordinary Shares purchased, the Company will have 282,260,661 Ordinary Shares in issue, of which 6,824,448 will be held in Treasury, and 13,465,175 Ordinary Non-Voting shares in issue.

The shares held in Treasury and the Ordinary Non-Voting shares do not carry voting rights. Therefore, the total number of voting rights in the Company is 275,436,213. This figure of 275,436,213 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.

Schedule of Purchases

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the “Market Abuse Regulation”), (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), a full breakdown of the individual trades made by BofA on behalf of the Company as part of the programme is detailed on the attached:

ICG PLC Weekly Trade Fills

Terms not defined here shall have the meaning as set out in the Strategic Partnership Announcement.

Enquiries:

Chris Hunt, Head of Corporate Development and Shareholder Relations, ICG
+44 (0) 20 3545 2020

Media:

Fiona Laffan, Global Head of Corporate Affairs, ICG
+44(0)20 3545 1510

Attachment

  • ICG PLC Weekly Trade Fills

Powered by SlickText.com

Hot this week

Transaction in Own Shares

ICG Enterprise Trust plc (the “Company”) 9 September...

NBPE Announces Transaction in Own Shares

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION...

Pharming Group to participate in September investor conferences

Leiden, the Netherlands, September 9, 2026: Pharming Group N.V. (“Pharming”)...

Topics

Transaction in Own Shares

ICG Enterprise Trust plc (the “Company”) 9 September...

NBPE Announces Transaction in Own Shares

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION...

Pharming Group to participate in September investor conferences

Leiden, the Netherlands, September 9, 2026: Pharming Group N.V. (“Pharming”)...

GENFIT Highlights Long-Term Commercial Opportunity for its MASH Diagnostics Technology

Simple, reliable and scalable blood-based testing could identify patients...
spot_img

Related Articles

Popular Categories

spot_img